secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTIVION, INC. (AORT)
CIK:        0000784199
Form:       8-K
Filed at:   2024-05-06T23:59:59+00:00
Accession:  0000784199-24-000169
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artivion Q1 revenue $97.4M (+17% YoY); nets $7.5M income vs loss; raises FY24 guidance
--------------------------------------------------------------------------------

- Revenue $97.4M, up 17% GAAP (16% constant currency) vs $83.2M in Q1 2023.
- Net income $7.5M ($0.18 diluted EPS) vs net loss ($13.5M) in Q1 2023; non-GAAP net income $2.6M ($0.06 EPS).
- Non-GAAP adjusted EBITDA rose 60% to $17.3M from $10.8M in Q1 2023.
- Revised FY24 constant-currency revenue growth guidance to 9%-12% (prev 8%-12%); revenue range $386M-$396M.
- Tissue processing +26% constant currency YoY; stent grafts +19%; Latin America +22% constant currency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/784199/000078419924000169/0000784199-24-000169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/784199/000078419924000169/aort-20240506.htm
  HTML page:      https://secwatch.observer/filing/0000784199-24-000169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer